Michael Gordon News
-
Merck & Co., Bristol-Myers Squibb Co. and Roche Holding AG have opened a new front against cancer with the next generation of experimental drugs that use the human immune system to seek and destroy tumor cells.
-
Jeff Vinik, in a move that echoes his departure 17 years ago from the Fidelity Magellan Fund, is shutting his hedge fund after making ill-timed bets on gold and the direction of stocks.
-
Adam Sender, general partner and founder of Exis Capital Management Inc., threw a birthday party for his daughter on Saturday.
-
President Barack Obama and Republican nominee Mitt Romney made competing assertions during their foreign policy debate yesterday in Boca Raton, Florida. How did they square with the facts?
-
An Arizona voter-approved law that decriminalizes the possession and sale of marijuana for medical uses isn’t pre-empted by the federal Controlled Substances Act and therefore isn’t unconstitutional, a state judge said.
-
Exelixis Inc. ’s experimental pill reduced malignant growths in the bones of 86 percent of men with prostate cancer and cut the spread of tumor cells in one-fourth of women with ovarian cancer in a company study.
-
Angelo Gordon & Co., the $24 billion firm started by John Angelo and Michael Gordon, plans a residential and commercial mortgage fund betting on a real estate recovery, according to a presentation.
-
Debevoise & Plimpton LLP partner Mary Jo White, who gained prominence prosecuting terrorists as U.S. attorney for Manhattan, was named by President Barack Obama to be chairman of the Securities and Exchange Commission.
-
Bondholder confidence is growing that U.S. commercial property is bottoming following the recovery in residential housing.
-
Boston Red Sox owners John W. Henry and Tom Werner have been cleared by the Premier League to complete their 300-million-pound ($478 million) purchase of England’s most successful soccer team, Liverpool.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page